Quantcast
Skip to main content
Environmental Health Perspectives Podcasts - The Researcher's Perspectives
Full
About EHP Publications Past Issues News By Topic Authors Subscribe Press International Inside EHP Email Alerts spacer
Environmental Health Perspectives (EHP) is a monthly journal of peer-reviewed research and news on the impact of the environment on human health. EHP is published by the National Institute of Environmental Health Sciences and its content is free online. Print issues are available by paid subscription.DISCLAIMER
spacer
NIEHS
NIH
DHHS
spacer
Current Issue

EHP Science Education Website




EHP on Twitter

AAAR

Comparative Toxicogenomics Database (CTD)

spacer
Environmental Health Perspectives Supplements Volume 104, Number S1, March 1996 Open Access
spacer
Environmental Health Issues

Andrew C. Todd, James G. Wetmur, Jacqueline M. Moline, James H. Godbold, Stephen M. Levin, and Philip J. Landrigan

Environmental Health Sciences Center, The Mount Sinai School of Medicine, New York, New York

Abstract

Although population exposure to lead has declined, chronic lead toxicity remains a major public health problem in the United States affecting millions of children and adults. Important gaps exist in knowledge of the pathophysiology of chronic lead intoxication. These gaps have impeded development of control strategies. To close current gaps in knowledge of chronic lead toxicity, we propose an integrated, multi-disciplinary, marker-based research program. This program combines a) direct measurement of individual lead burden by 109Cd X-ray fluorescence analysis of lead in bone, b) determination of ALA-D phenotype, an index of individual susceptibility to lead, and c) assessments of subclinical injury produced by lead in the kidneys, nervous system and reproductive organs. Data from this research will provide answers to questions of great public health importance: a) Are current environmental and occupational standards adequate to prevent chronic lead intoxication? b) Is lead mobilized from the skeleton during pregnancy or lactation to cause fetal toxicity? c) Is lead mobilized from bone during menopause to cause neurotoxicity? d) What is the significance of genetic variation in determining susceptibility to lead? e) What is the contribution of lead to hypertension, renal disease, chronic neurodegenerative disease or declining sperm counts? f) Is chelation therapy effective in reducing body lead burden in persons with chronic overexposure to lead? -- Environ Health Perspect 104(Suppl 1) :00-00 (1996)

Key words: , , , , ,


The full version of this article is available for free in HTML format.
spacer
 
Open Access Resources | Call for Papers | Career Opportunities | Buy EHP Publications | Advertising Information | Subscribe to the EHP News Feeds News Feeds | Inspector General USA.gov

Download Adobe Acrobat Reader to view PDF files located on this site.